Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 7
Submit an article Journal homepage
2,028
Views
2
CrossRef citations to date
0
Altmetric
Author's View

Retrieval of functional TCRs from single antigen-specific T cells: Toward individualized TCR-engineered therapies

Tana OmokokoTRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany;BioNTech Cell & Gene Therapies GmbH; Mainz, Germany
,
Petra SimonTRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany;BioNTech Cell & Gene Therapies GmbH; Mainz, Germany
,
Özlem TüreciTRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany
&
Ugur SahinTRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University; Mainz, Germany;BioNTech Cell & Gene Therapies GmbH; Mainz, Germany;Research Center for Immunotherapy (FZI) at the University Medical Hospital; Johannes Gutenberg-University; Mainz, GermanyCorrespondence[email protected]
Article: e1005523 | Received 04 Jan 2015, Accepted 06 Jan 2015, Published online: 17 Jun 2015

References

  • Kershaw MH, Westwood JA, Darcy PK. Gene-engineered T cells for cancer therapy. Nat Rev Cancer 2013; 13:525–41; PMID:23880905; http://dx.doi.org/10.1038/nrc3565
  • Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med 2011; 365:725–33; PMID:21830940; http://dx.doi.org/10.1056/NEJMoa1103849
  • Hinrichs CS, Restifo NP. Reassessing target antigens for adoptive T-cell therapy. Nat Biotechnol 2013; 31:999–1008; PMID:24142051; http://dx.doi.org/10.1038/nbt.2725
  • Simon P, Omokoko TA, Breitkreuz A, Hebich L, Kreiter S, Attig S, Konur A, Britten CM, Paret C, Dhaene K, et al. Functional TCR retrieval from single antigen-specific human T cells reveals multiple novel epitopes. Cancer Immunol Res 2014; 2:1230–44; PMID:25245536; http://dx.doi.org/10.1158/2326-6066.CIR-14-0108
  • Wolfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995; 269:1281–4; PMID:7652577; http://dx.doi.org/10.1126/science.7652577
  • Gubin MM, Zhang X, Schuster H, Caron E, Ward JP, Noguchi T, Ivanova Y, Hundal J, Arthur CD, Krebber WJ, et al. Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 2014; 515:577–81; PMID:25428507; http://dx.doi.org/10.1038/nature13988
  • Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, Walsh LA, Postow MA, Wong P, Ho TS, et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med 2014; 371:2189–99; PMID:25409260; http://dx.doi.org/10.1056/NEJMoa1406498
  • Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, Wunderlich JR, Somerville RP, Hogan K, Hinrichs CS, et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 2014; 344:641–5; PMID:24812403; http://dx.doi.org/10.1126/science.1251102
  • Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 2012; 482:400–4; PMID:22318521; http://dx.doi.org/10.1038/nature10755
  • Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, et al. Exploiting the mutanome for tumor vaccination. Cancer Res 2012; 72:1081–91; PMID:22237626; http://dx.doi.org/10.1158/0008-5472.CAN-11-3722

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.